Publications by authors named "T Hervig"
Background Aims: The relationship between blood establishments and advanced cellular therapies is evident in several European countries, with some involved in research and development and/or in manufacturing. The aim of the present study was to understand the advanced therapy medicinal product (ATMP) infrastructural, regulatory and logistic requirements needed for the Irish Blood Transfusion Service to support advanced therapeutics in Ireland.
Methods: An online survey consisting of 13 questions was distributed in a targeted manner to the identified ATMP stakeholders in Ireland, namely those working in industry, health care, regulatory agencies or education.
Article Synopsis
- Several high-income countries have ended the practice of deferring gay, bisexual, and other men who have sex with men (MSM) from donating blood, moving towards a gender-neutral donor selection approach.
- An international symposium held in April 2023 brought together experts to discuss the impacts of this shift on transfusion safety and the challenges of implementing such policies.
- Findings indicate that most countries adopted similar strategies for this transition, which were positively received by stakeholders and showed reassuring safety data, although further research on HIV risks is needed.
Background: At the start of the pandemic, the Norwegian Directorate of Health and Norwegian blood banks initiated the production of COVID-19 convalescent plasma within the framework of clinical studies. In this article we describe the blood donors who participated.
Material And Method: Blood donors who had recovered from COVID-19 were recruited to donate single donor plasma for the purpose of patient treatment.
Background: In Norway, treatment with COVID-19 convalescent plasma has been given through the NORPLASMA project. The treatment was initially offered to critically ill patients after an individual assessment, but from December 2020, the indication was limited to critically ill, immunocompromised patients. In this article we describe clinical characteristics, comorbidity and mortality in patients who received convalescent plasma in these two periods.
View Article and Find Full Text PDF